Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Tetrahydrobiopterin in CKD and Albuminuria
NCT00625820Phase 2Completed
- Sponsor
- University of Michigan
- Start
- May 2008
- Primary completion
- Sep 2008
- Modality
- Allosteric Modulators, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of sapropterin in chronic kidney disease (CKD), albuminuria, sponsored by University of Michigan. Started May 2008; status: completed.
02
Drugs
sapropterin
03
Conditions
chronic kidney disease (CKD)albuminuria
Beyond the preview
Go deeper on NCT00625820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00625820.